Digoxin and Senolysis in Heart Failure and Diabetes Mellitus
Conditions: Heart Failure, Systolic; Diabetes Mellitus, Type 2 Interventions: Drug: Digoxin 0.125 MG Sponsors: University of Leeds Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Research